NuVasive’s XLIF procedure is backed by 10-plus years of clinical evidence.
Here are four observations:
1. The market is set to hit about $2.6 billion by 2024.
2. In 2016, the market was worth about $1.6 billion.
3. Key drivers include the increasing demand of minimally invasive procedures and growing number of spinal disorder cases.
4. The procedure’s costliness, unfavorable reimbursements and a boost in alternative treatments will hinder market growth.
More articles on MIS:
Life Spine launches SI joint fixation screw system
Columbia University Medical Center performs 1st surgery using Titan Medical’s Sport Surgical System: 5 insights
Florida Hospital 1st in US to install minimally invasive surgical robot: 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.